Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

16.9K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
16.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Burla et al. Reduced CHMP7 Expression Compromises Telomere Integrity in Mammalian Cells. <i>Cells</i> 2026, <i>15</i>, 256.

Cells·2026
Same author

Optical genome mapping reveals multiple apoptotic and cell-cycle pathway aberrations in B-cell prolymphocytic leukemia: a report of three cases.

Cancer genetics·2026
Same author

Reduced CHMP7 Expression Compromises Telomere Integrity in Mammalian Cells.

Cells·2026
Same author

Characterization of Copy Number Variants in Hereditary Cancer Patients Through NGS Shows a Distinctive PALB2 Contribution to the Diagnostic Yield.

Human mutation·2026
Same author

Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications.

NPJ breast cancer·2025
Same author

Clinical outcome and proportion of hereditary cancer genes gPV in TNBC: the HEaRTBeat study.

NPJ breast cancer·2025
Same journal

Isolation of Mesenchymal Stem Cell-Derived Extracellular Vesicles.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Modeling Melanoma Immune Surveillance by CAR-T Cells in Human Skin Organoids.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Stepwise Optimization of a Matrigel-Based In Vitro Angiogenesis Assay for Reproducible and Quantifiable 2D-Tube Formation Using HUVECs.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Quantifying Mechanical Properties of Fresh Ovarian Tissue with Optical Brillouin Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

3D Chromatin Architecture During Early Development: New Methods and New Findings.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Metabolic Plasticity in Embryogenesis Throughout the Lens of NAD<sup></sup>.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
06:01

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions

Published on: January 7, 2019

6.5K

DNA microarray to analyze adenovirus-host interactions.

Stefania Piersanti1, Enrico Tagliafico, Isabella Saggio

  • 1Dipartimento di Biologia e Biotecnologie, Sapienza, Università di Roma, Roma, Italy.

Methods in Molecular Biology (Clifton, N.J.)
|October 18, 2013
PubMed
Summary
This summary is machine-generated.

Gene chips identify molecular toxicity of viral vectors, revealing cell cycle changes and immune responses. This protocol aids safe clinical applications of gene therapy vectors.

More Related Videos

Using a Pan-Viral Microarray Assay Virochip to Screen Clinical Samples for Viral Pathogens
13:45

Using a Pan-Viral Microarray Assay Virochip to Screen Clinical Samples for Viral Pathogens

Published on: April 27, 2011

19.2K
A Quantitative Dot Blot Assay for AAV Titration and Its Use for Functional Assessment of the Adeno-associated Virus Assembly-activating Proteins
14:49

A Quantitative Dot Blot Assay for AAV Titration and Its Use for Functional Assessment of the Adeno-associated Virus Assembly-activating Proteins

Published on: June 12, 2018

13.2K

Related Experiment Videos

Last Updated: May 6, 2026

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
06:01

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions

Published on: January 7, 2019

6.5K
Using a Pan-Viral Microarray Assay Virochip to Screen Clinical Samples for Viral Pathogens
13:45

Using a Pan-Viral Microarray Assay Virochip to Screen Clinical Samples for Viral Pathogens

Published on: April 27, 2011

19.2K
A Quantitative Dot Blot Assay for AAV Titration and Its Use for Functional Assessment of the Adeno-associated Virus Assembly-activating Proteins
14:49

A Quantitative Dot Blot Assay for AAV Titration and Its Use for Functional Assessment of the Adeno-associated Virus Assembly-activating Proteins

Published on: June 12, 2018

13.2K

Area of Science:

  • Molecular Biology
  • Toxicology
  • Gene Therapy

Background:

  • Assessing viral vector molecular toxicity is crucial for safe human clinical trials.
  • DNA chips (gene chips) enable high-throughput analysis of transduced cell profiles.
  • Previous studies utilized gene chips to identify vector-specific toxicities.

Purpose of the Study:

  • To detail a protocol for using gene chips to analyze the toxicogenomic signature of helper-dependent adenoviral vectors.
  • To provide guidelines applicable to various experimental contexts involving viral vector toxicity.
  • To highlight the importance of in silico data analysis for interpreting gene chip results.

Main Methods:

  • Utilized DNA chips (gene chips) for high-throughput evaluation of transduced cell profiles.
  • Applied the protocol to study human and canine helper-dependent adenoviral vectors.
  • Included detailed procedures for in silico elaboration of gene chip raw data.

Main Results:

  • Identified vector-specific properties, including cell cycle alterations induced by vector genomic DNA.
  • Detected activation of specific innate immune pathways attributable to viral particles.
  • Demonstrated the utility of gene chips in dissecting viral vector toxicogenomic signatures.

Conclusions:

  • Gene chips are effective tools for defining the molecular toxicity of viral vectors.
  • The described protocol facilitates the study of adenoviral vector toxicity.
  • This approach supports the safe clinical translation of gene therapy vectors.